Cargando…
Reviewing the Regulators of COL1A1
The collagen family contains 28 proteins, predominantly expressed in the extracellular matrix (ECM) and characterized by a triple-helix structure. Collagens undergo several maturation steps, including post-translational modifications (PTMs) and cross-linking. These proteins are associated with multi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298483/ https://www.ncbi.nlm.nih.gov/pubmed/37373151 http://dx.doi.org/10.3390/ijms241210004 |
_version_ | 1785064126638194688 |
---|---|
author | Devos, Hanne Zoidakis, Jerome Roubelakis, Maria G. Latosinska, Agnieszka Vlahou, Antonia |
author_facet | Devos, Hanne Zoidakis, Jerome Roubelakis, Maria G. Latosinska, Agnieszka Vlahou, Antonia |
author_sort | Devos, Hanne |
collection | PubMed |
description | The collagen family contains 28 proteins, predominantly expressed in the extracellular matrix (ECM) and characterized by a triple-helix structure. Collagens undergo several maturation steps, including post-translational modifications (PTMs) and cross-linking. These proteins are associated with multiple diseases, the most pronounced of which are fibrosis and bone diseases. This review focuses on the most abundant ECM protein highly implicated in disease, type I collagen (collagen I), in particular on its predominant chain collagen type I alpha 1 (COLα1 (I)). An overview of the regulators of COLα1 (I) and COLα1 (I) interactors is presented. Manuscripts were retrieved searching PubMed, using specific keywords related to COLα1 (I). COL1A1 regulators at the epigenetic, transcriptional, post-transcriptional and post-translational levels include DNA Methyl Transferases (DNMTs), Tumour Growth Factor β (TGFβ), Terminal Nucleotidyltransferase 5A (TENT5A) and Bone Morphogenic Protein 1 (BMP1), respectively. COLα1 (I) interacts with a variety of cell receptors including integrinβ, Endo180 and Discoidin Domain Receptors (DDRs). Collectively, even though multiple factors have been identified in association to COLα1 (I) function, the implicated pathways frequently remain unclear, underscoring the need for a more spherical analysis considering all molecular levels simultaneously. |
format | Online Article Text |
id | pubmed-10298483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102984832023-06-28 Reviewing the Regulators of COL1A1 Devos, Hanne Zoidakis, Jerome Roubelakis, Maria G. Latosinska, Agnieszka Vlahou, Antonia Int J Mol Sci Review The collagen family contains 28 proteins, predominantly expressed in the extracellular matrix (ECM) and characterized by a triple-helix structure. Collagens undergo several maturation steps, including post-translational modifications (PTMs) and cross-linking. These proteins are associated with multiple diseases, the most pronounced of which are fibrosis and bone diseases. This review focuses on the most abundant ECM protein highly implicated in disease, type I collagen (collagen I), in particular on its predominant chain collagen type I alpha 1 (COLα1 (I)). An overview of the regulators of COLα1 (I) and COLα1 (I) interactors is presented. Manuscripts were retrieved searching PubMed, using specific keywords related to COLα1 (I). COL1A1 regulators at the epigenetic, transcriptional, post-transcriptional and post-translational levels include DNA Methyl Transferases (DNMTs), Tumour Growth Factor β (TGFβ), Terminal Nucleotidyltransferase 5A (TENT5A) and Bone Morphogenic Protein 1 (BMP1), respectively. COLα1 (I) interacts with a variety of cell receptors including integrinβ, Endo180 and Discoidin Domain Receptors (DDRs). Collectively, even though multiple factors have been identified in association to COLα1 (I) function, the implicated pathways frequently remain unclear, underscoring the need for a more spherical analysis considering all molecular levels simultaneously. MDPI 2023-06-11 /pmc/articles/PMC10298483/ /pubmed/37373151 http://dx.doi.org/10.3390/ijms241210004 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Devos, Hanne Zoidakis, Jerome Roubelakis, Maria G. Latosinska, Agnieszka Vlahou, Antonia Reviewing the Regulators of COL1A1 |
title | Reviewing the Regulators of COL1A1 |
title_full | Reviewing the Regulators of COL1A1 |
title_fullStr | Reviewing the Regulators of COL1A1 |
title_full_unstemmed | Reviewing the Regulators of COL1A1 |
title_short | Reviewing the Regulators of COL1A1 |
title_sort | reviewing the regulators of col1a1 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298483/ https://www.ncbi.nlm.nih.gov/pubmed/37373151 http://dx.doi.org/10.3390/ijms241210004 |
work_keys_str_mv | AT devoshanne reviewingtheregulatorsofcol1a1 AT zoidakisjerome reviewingtheregulatorsofcol1a1 AT roubelakismariag reviewingtheregulatorsofcol1a1 AT latosinskaagnieszka reviewingtheregulatorsofcol1a1 AT vlahouantonia reviewingtheregulatorsofcol1a1 |